C
Cohance Lifesciences Ltd
Pharmaceuticals
MIDCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 129.91 | 36.40 |
| PB Ratio | 18.91 | 5.86 |
| Dividend Yield | — | 0.59% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
C
Cohance Lifesciences Ltd
Cohance Lifesciences Limited is a technology-driven CDMO in India, offering custom synthesis, process R&D, and manufacturing services for pharmaceuticals and specialty chemicals.
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions